Chun Chao to Papillomavirus Vaccines
This is a "connection" page, showing publications Chun Chao has written about Papillomavirus Vaccines.
Connection Strength
4.463
-
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
Score: 0.748
-
Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017 Feb; 216(2):151.e1-151.e9.
Score: 0.495
-
Human papillomavirus vaccine series completion: Qualitative information from providers within an integrated healthcare organization. Vaccine. 2016 06 24; 34(30):3515-21.
Score: 0.474
-
A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health. 2015 Jan; 56(1):85-90.
Score: 0.432
-
Evaluation of autoimmune safety signal in observational vaccine safety studies. Hum Vaccin Immunother. 2012 Sep; 8(9):1302-4.
Score: 0.370
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
Score: 0.352
-
Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol. 2010 Feb 01; 171(3):357-67.
Score: 0.309
-
Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc. 2009 Oct; 84(10):864-70.
Score: 0.304
-
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009 Jun; 99(6):1137-42.
Score: 0.294
-
Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
Score: 0.159
-
Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine. Hum Vaccin Immunother. 2018 02 01; 14(2):412-419.
Score: 0.134
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.109
-
Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections. Am J Public Health. 2013 Sep; 103(9):e63-8.
Score: 0.099
-
Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
Score: 0.095
-
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine. 2012 Jun 29; 30(31):4585-7.
Score: 0.091